99 related articles for article (PubMed ID: 11317533)
1. [Risk factors for bone marrow involvement in Hodgkin's disease].
Kanaev SV; Novikov SN; Zhukova LA; Pozharisskiĭ KM; Leenman EE; Gershanovich ML
Vopr Onkol; 2001; 47(1):39-44. PubMed ID: 11317533
[TBL] [Abstract][Full Text] [Related]
2. Role of bone marrow trephine biopsy in the diagnosis of marrow involvement in Hodgkin's disease.
Subramanian R; Basu D; Badhe B; Dutta TK
Indian J Pathol Microbiol; 2007 Jul; 50(3):640-3. PubMed ID: 17883170
[TBL] [Abstract][Full Text] [Related]
3. [Factors of an unfavorable prognosis in patients with B-cell chronic lymphoid leukemia: a retrospective analysis of 206 cases].
Nikitin EA; Lorie IuIu; Melikian AL; Samoĭlova RS; Bulycheva TI; Obukhova TN; Kaplanskaia IB; Doronin VA; Kolosova LIu; Goriacheva SR
Ter Arkh; 2003; 75(7):38-47. PubMed ID: 12934480
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow involvement in Hodgkin's disease -- clinicopathological study of seven cases.
Chopra R; Kumar S; Rana R; Zachariah A
Indian J Pathol Microbiol; 1995 Jul; 38(3):267-71. PubMed ID: 8819658
[TBL] [Abstract][Full Text] [Related]
5. [Clinico-pathological characteristics, response to therapy and survival of patients with bone marrow infiltration by Hodgkin's lymphoma].
Marisavljević D; Bosković D; Petrović M; Colović M; Radosević-Radojković N; Jovanovitsh V
Srp Arh Celok Lek; 1995; 123(3-4):68-72. PubMed ID: 16296226
[TBL] [Abstract][Full Text] [Related]
6. Disseminated tumor cells in bone marrow of patients with transitional cell carcinoma: immunocytochemical detection and correlation with established prognostic indicators.
Hofmann T; Riesenberg R; Buchner A; Zimmermann W; Hofstetter A; Oberneder R
J Urol; 2003 Apr; 169(4):1303-7. PubMed ID: 12629348
[TBL] [Abstract][Full Text] [Related]
7. Patterns of disease recurrence influenced by hematogenous tumor cell dissemination in patients with cervical carcinoma of the uterus.
Janni W; Hepp F; Strobl B; Rack B; Rjosk D; Kentenich C; Schindlbeck C; Hantschmann P; Pantel K; Sommer H; Braun S
Cancer; 2003 Jan; 97(2):405-11. PubMed ID: 12518364
[TBL] [Abstract][Full Text] [Related]
8. [Outcomes prediction for children with Hodgkin's disease].
Kolygin BA; Anishkin MIu
Vopr Onkol; 2006; 52(3):322-5. PubMed ID: 17191706
[TBL] [Abstract][Full Text] [Related]
9. Influence of biologic markers on the outcome of Hodgkin's lymphoma: a study by the Spanish Hodgkin's Lymphoma Study Group.
Montalbán C; García JF; Abraira V; González-Camacho L; Morente MM; Bello JL; Conde E; Cruz MA; García-Sanz R; García-Laraña J; Grande C; Llanos M; Martínez R; Flores E; Méndez M; Ponderós C; Rayón C; Sánchez-Godoy P; Zamora J; Piris MA;
J Clin Oncol; 2004 May; 22(9):1664-73. PubMed ID: 15117989
[TBL] [Abstract][Full Text] [Related]
10. [The influence of the hemoglobin concentration on the hematogenous tumor cell dissemination at the time of the initial diagnosis of breast cancer].
Janni W; Strobl B; Rack B; Rjosk D; Schindlbeck C; Hantschmann P; Kentenich C; Sigg W; Zerzer M; Sommer H
Dtsch Med Wochenschr; 2002 Jan; 127(3):71-7. PubMed ID: 11797143
[TBL] [Abstract][Full Text] [Related]
11. Limited usefulness of CA125 measurement in the management of Hodgkin's and non-Hodgkin's lymphoma.
Bonnet C; Beguin Y; Fassotte MF; Seidel L; Luyckx F; Fillet G
Eur J Haematol; 2007 May; 78(5):399-404. PubMed ID: 17419741
[TBL] [Abstract][Full Text] [Related]
12. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S
Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
[TBL] [Abstract][Full Text] [Related]
13. Is bone marrow trephine biopsy always mandatory in staging Hodgkin's disease?
Cavalieri E; Anselmo AP; Gianfelici V; Frattarelli N; Pescarmona E; Foà R; Pulsoni A
Haematologica; 2005 Jan; 90(1):134-6. PubMed ID: 15642684
[TBL] [Abstract][Full Text] [Related]
14. Hodgkin's and non-Hodgkin's lymphoma of the head and neck.
Urquhart A; Berg R
Laryngoscope; 2001 Sep; 111(9):1565-9. PubMed ID: 11568605
[TBL] [Abstract][Full Text] [Related]
15. [Importance of determination of serum beta-2-microglobulin levels in patients with Hodgkin's lymphoma].
Raida L; Papajík T; Hlusí A; Faber E; Urbanová R; Heczko M; Jancíková M; Zapletalová J; Komenda S; Indrák K
Vnitr Lek; 2002 Feb; 48(2):91-5. PubMed ID: 11949228
[TBL] [Abstract][Full Text] [Related]
16. Hodgkin's lymphoma in adults--clinical features.
Jose BO; Koerner P; Spanos WJ; Paris KJ; Silverman CL; Yashar C; Carrascosa LB
J Ky Med Assoc; 2005 Jan; 103(1):15-7. PubMed ID: 15682982
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow biopsy in Hodgkin's disease.
Sharma S; Ahuja A; Murari M
Indian J Pathol Microbiol; 2004 Jul; 47(3):364-6. PubMed ID: 16295425
[TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of soluble HLA-I and beta2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's disease.
Albitar M; Vose JM; Johnson MM; Do KA; Day A; Jilani I; Kantarjian H; Keating M; O'Brien SM; Verstovsek S; Armitage JO; Giles FJ
Leuk Res; 2007 Feb; 31(2):139-45. PubMed ID: 16545870
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin's disease: potential for a prognostic factor.
Weihrauch MR; Manzke O; Beyer M; Haverkamp H; Diehl V; Bohlen H; Wolf J; Schultze JL
Cancer Res; 2005 Jul; 65(13):5516-9. PubMed ID: 15994922
[TBL] [Abstract][Full Text] [Related]
20. Serum soluble interleukin-2 receptor, beta2-microglobulin, lactate dehydrogenase and erythrocyte sedimentation rate in children with Hodgkin's lymphoma.
Bien E; Balcerska A
Scand J Immunol; 2009 Nov; 70(5):490-500. PubMed ID: 19874554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]